Daria Pagliara

Medicine & Life Sciences

1. Hematopoietic Stem Cell Transplantation 100%
2. T-Lymphocytes 62%
3. Graft vs Host Disease 43%
4. Leukemia 37%
5. Transplants 36%
6. Unrelated Donors 31%
7. Child 30%
8. B-Lymphocytes 29%
9. Fanconi Anemia 28%
10. Tissue Donors 27%
11. Pediatrics 25%
12. Stem Cell Transplantation 22%
13. Natural Killer Cells 19%
14. Chimeric Antigen Receptors 17%
15. Human Herpesvirus 4 16%
16. Incidence 15%
17. Zoledronic Acid 12%
18. Thomsen-Friedenreich antibodies 12%
19. Globulins 11%
20. Busulfan 10%
21. Aplastic Anaemia 10%
22. Whole-Body Irradiation 10%
23. Cytotoxic T-Lymphocytes 10%
24. Hematologic Neoplasms 9%
25. Cell- and Tissue-Based Therapy 9%
26. Neuroblastoma 9%
27. Cell Transplantation 9%
28. Hematopoietic Stem Cells 8%
29. Neoplasms 8%
30. Interleukin-7 8%
31. Regulatory T-Lymphocytes 8%
32. Thalassemia 8%
33. Cytokines 8%
34. Mesenchymal Stem Cells 7%
35. Interleukin-15 7%
36. treosulfan 7%
37. Survival 7%
38. Mutation 7%
39. Fanconi Anemia Complementation Group Proteins 6%
40. Colonic Pseudo-Obstruction 6%
41. Transplantation 6%
42. Haploidentical Transplantation 6%
43. Juvenile Myelomonocytic Leukemia 6%
44. Cytomegalovirus 6%
45. HLA Antigens 6%
46. Precursor Cell Lymphoblastic Leukemia-Lymphoma 6%
47. Rabbits 6%
48. Lymphoproliferative Disorders 5%
49. Recurrence 5%
50. CTLA-4 Antigen 5%